Alessandra Pavesio
Chief Tech/Sci/R&D Officer presso Bioventus LLC
Patrimonio netto: 802 386 $ in data 31/03/2024
Profilo
Alessandra Pavesio is currently the Chief Scientific Officer & Senior Vice President at Bioventus LLC since 2013.
Previously, she held the position of Vice President-Research & Development at Anika Therapeutics, Inc. from 2010 to 2011.
She also served as Vice President-Research & Development at Anika Therapeutics Srl.
Additionally, Ms. Pavesio worked as the Chief Science Officer & Senior Vice President at Bioventus, Inc. from 2013 to 2022.
She is a graduate of the University of Turin.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOVENTUS, INC. CLASS A
0.24% | 12/04/2023 | 154 305 ( 0.24% ) | 802 386 $ | 31/03/2024 |
Posizioni attive di Alessandra Pavesio
| Società | Posizione | Inizio |
|---|---|---|
Bioventus LLC
 Bioventus LLC Medical SpecialtiesHealth Technology Bioventus LLC is a holding company, which manufactures medical equipment. It develops bone healing devices and distributes osteoarthritis injection therapies. Its products include ultrasound bone healing device, joint therapies, and osteoarthritis injection therapies. The company was founded in 2012 and is headquartered in Durham, NC. | Chief Tech/Sci/R&D Officer | 05/08/2013 |
Precedenti posizioni note di Alessandra Pavesio
| Società | Posizione | Fine |
|---|---|---|
| BIOVENTUS INC. | Chief Tech/Sci/R&D Officer | 01/12/2022 |
| ANIKA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2011 |
Anika Therapeutics Srl
 Anika Therapeutics Srl Chemicals: SpecialtyProcess Industries Part of Anika Therapeutics, Inc., Anika Therapeutics Srl is an Italian joint preservation company that focuses on early intervention orthopedic care. The private company is based in Padua, Italy. Anika offers a range of treatment options for joint preservation. Anika Therapeutics was acquired by Anika Therapeutics, Inc. from Fidia Farmaceutici SpA on December 31, 2009 for $33.87 million. | Chief Tech/Sci/R&D Officer | - |
Formazione di Alessandra Pavesio
| University of Turin | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| BIOVENTUS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Anika Therapeutics Srl
Anika Therapeutics Srl Chemicals: SpecialtyProcess Industries Part of Anika Therapeutics, Inc., Anika Therapeutics Srl is an Italian joint preservation company that focuses on early intervention orthopedic care. The private company is based in Padua, Italy. Anika offers a range of treatment options for joint preservation. Anika Therapeutics was acquired by Anika Therapeutics, Inc. from Fidia Farmaceutici SpA on December 31, 2009 for $33.87 million. | Process Industries |
Bioventus LLC
Bioventus LLC Medical SpecialtiesHealth Technology Bioventus LLC is a holding company, which manufactures medical equipment. It develops bone healing devices and distributes osteoarthritis injection therapies. Its products include ultrasound bone healing device, joint therapies, and osteoarthritis injection therapies. The company was founded in 2012 and is headquartered in Durham, NC. | Health Technology |
- Borsa valori
- Insiders
- Alessandra Pavesio
